Jasim Uddin ☆ Bangladesh, 2018-06-20 15:29 (2520 d 04:56 ago) Posting: # 18929 Views: 3,417 |
|
Dear Sirs Does anyone know about BE Study design of Immediate Release Formulation against Extended Release Formulation? We manufacture Potassium Chloride 600 mg IR tablet. But no RLD is available as IR tablet. RLD SLOW-K 600 mg of Novartis is available as ER tablet. Is it possible to design BE study of our IR formulation of Potassium Chloride 600 mg against SLOW-K 600 mg ER tablet? Would appreciate kind advice of the experts in this forum. Kind regards Jasim Edit: Category changed; see also this post #1. [Helmut] |
Jasim Uddin ☆ Bangladesh, 2018-06-24 12:28 (2516 d 07:57 ago) @ Jasim Uddin Posting: # 18955 Views: 2,538 |
|
Hi Sir Helmut Can you please help me out in the following issue? Regards Jasim Edit: Relax; see also this post #9. Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5! [Helmut] |